Groundbreaking Ovarian Cancer Vaccine at an "Exciting" Moment, Lead Scientist Says
Scientists at Oxford have started developing an ovarian cancer vaccine that imbues the immune system with the ability to recognize and attack early-stage ovarian cancer cells. The research is currently focusing on women with one or two specific mutations known to be linked to a higher risk of breast and ovarian cancer. The vaccine still needs to go through several rounds of trials, a process that could take years, before human clinical trials can begin.